作者: Daniel Zagury , Helene Le Buanec , Bernard Bizzini
DOI:
关键词:
摘要: The invention concerns a pharmaceutical composition comprising, as the active ingredient, human natural antibodies of IgG isotype, that neutralize activity cytokine selected from VEGF, IFNα, IL-4, TNFα and TGFβ, said neutralizing inhibiting at least 50% maximum biological induced by an amount ranging 0.006 ng to 0.05 in vitro.